Pre-exposure prophylaxis (e.g., monoclonal antibodies) may be considered to complement COVID-19 vaccination.3-dose series at 0, 4, 8 weeks (Moderna) or 3-dose series at 0, 3, 7 weeks (Pfizer-BioNTech).Persons who are moderately or severely immunocompromised 2- or 3- dose primary series and booster ( see notes)ġ dose Tdap each pregnancy 1 dose Td/Tdap for wound management ( see notes)ġ dose Tdap, then Td or Tdap booster every 10 yearsĢ doses for immunocompromising conditions ( see notes)Ģ or 3 doses depending on age at initial vaccination or conditionĢ, 3, or 4 doses depending on vaccine or conditionġ or 2 doses depending on indication, see notes for booster recommendationsĢ or 3 doses depending on vaccine and indication, see notes for booster recommendations
0 kommentar(er)
